Cardinal Health CEO Michael C. Kaufmann Sells 50,216 Shares (CAH)
Cardinal Health (NYSE:CAH) CEO Michael C. Kaufmann unloaded 50,216 shares of the stock on the open market in a transaction dated Thursday, September 4th. The stock was sold at an average price of $74.95, for a total transaction of $3,763,689.20. Following the transaction, the chief executive officer now directly owns 118,576 shares of the company’s stock, valued at approximately $8,887,271. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of Cardinal Health (NYSE:CAH) traded up 0.59% on Friday, hitting $74.74. 152,485 shares of the company’s stock traded hands. Cardinal Health has a 52 week low of $49.65 and a 52 week high of $75.00. The stock has a 50-day moving average of $72.0 and a 200-day moving average of $70.0. The company has a market cap of $25.162 billion and a price-to-earnings ratio of 21.99.
Cardinal Health (NYSE:CAH) last released its earnings data on Monday, August 4th. The company reported $0.83 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.81 by $0.02. The company had revenue of $2.90 billion for the quarter, compared to the consensus estimate of $21.88 billion. During the same quarter in the previous year, the company posted $0.79 earnings per share. The company’s revenue for the quarter was down 9.9% on a year-over-year basis. On average, analysts predict that Cardinal Health will post $4.22 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be paid a dividend of $0.3425 per share. This represents a $1.37 annualized dividend and a dividend yield of 1.84%. The ex-dividend date is Monday, September 29th.
A number of research firms have recently commented on CAH. Analysts at Argus reiterated a “buy” rating on shares of Cardinal Health in a research note on Monday, August 18th. They now have a $71.43 price target on the stock, down previously from $83.00. Separately, analysts at Barclays reiterated an “overweight” rating on shares of Cardinal Health in a research note on Tuesday, August 5th. They now have a $82.00 price target on the stock, up previously from $77.00. Finally, analysts at Credit Suisse reiterated an “outperform” rating on shares of Cardinal Health in a research note on Tuesday, August 5th. They now have a $80.00 price target on the stock, up previously from $76.00. Three research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $77.93.
Cardinal Health, Inc is a healthcare services company providing pharmaceutical and medical products and services to pharmacies, hospitals, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with Analyst Ratings Network's FREE daily email newsletter.